Showing 1,321 - 1,340 results of 164,542 for search '(( 2 a decrease ) OR ( 5 ((((wt decrease) OR (mean decrease))) OR (we decrease)) ))', query time: 2.39s Refine Results
  1. 1321
  2. 1322
  3. 1323
  4. 1324

    FAK, but not Pyk2 is required for GPVI-mediated ROS generation and platelet aggregation. A. by Naadiya Carrim (664456)

    Published 2014
    “…<p>Washed human platelets (2.5×10<sup>8</sup>/mL) preloaded with 10 µM H<sub>2</sub>DCFDA (for ROS experiments only) were pre-treated with vehicle control (0.1% DMSO), FAK inhibitor (1 µM PF-228), Pyk2 inhibitor (10 µM Tyrphostin A9) or Syk inhibitor (5 µM BAY), then stimulated with 1 µg/mL CRP and monitored for ROS generation (i) and platelet aggregation (ii). …”
  5. 1325
  6. 1326

    Decreased MCM2-6 in Drosophila S2 Cells Does Not Generate Significant DNA Damage or Cause a Marked Increase in Sensitivity to Replication Interference by Isabelle Crevel (119003)

    Published 2011
    “…Here we show that Drosophila S2 cells do not appear to show the same degree of sensitivity to MCM2-6 reduction. …”
  7. 1327
  8. 1328
  9. 1329
  10. 1330

    Fig 5 - by Geoff Harley (14593275)

    Published 2023
    “…In the PFKFB2 KI mice, there was decreased mRNA expression of F4.80 and TNF-α with the addition of metformin (<b>A, B</b> **p = 0.0024, *p = 0.0277 respectively). …”
  11. 1331
  12. 1332

    DataSheet_1_Imiquimod Boosts Interferon Response, and Decreases ACE2 and Pro-Inflammatory Response of Human Bronchial Epithelium in Asthma.pdf by Juan José Nieto-Fontarigo (11800142)

    Published 2021
    “…Background<p>Both anti-viral and anti-inflammatory bronchial effects are warranted to treat viral infections in asthma. We sought to investigate if imiquimod, a TLR7 agonist, exhibits such dual actions in ex vivo cultured human bronchial epithelial cells (HBECs), targets for SARS-CoV-2 infectivity.…”
  13. 1333

    <i>Neisseria meningitidis</i> Type IV Pili Composed of Sequence Invariable Pilins Are Masked by Multisite Glycosylation by Joseph Gault (427444)

    Published 2015
    “…Unlike class I pilins that carry a single glycan, we found that class II pilins display up to 5 glycosylation sites per monomer on the pilus surface. …”
  14. 1334

    Decreased F4/80<sup>+</sup> macrophages in the presence of PLD inhibitors using IF microscopy of lung sections. by Karen M. Henkels (3350273)

    Published 2016
    “…(<b>A,A’,E</b>) Tissues from non-xenographed controls; (<b>B,B’,F</b>) from Xenotransplanted controls with Alzet pumps delivering vehicle; (<b>C,C’,G</b>) Xenotransplanted with Alzet pumps delivering vehicle FIPI or (<b>D,D’,H</b>) VU0155072-2. …”
  15. 1335

    Image_1_miR-144-5p and miR-451a Inhibit the Growth of Cholangiocarcinoma Cells Through Decreasing the Expression of ST8SIA4.tif by Wan Fu (3681799)

    Published 2021
    “…This study aimed to investigate the action mechanism of miR-144-5p and miR-451a in cholangiocarcinoma. We found that miR-144-5p and miR-451a were significantly decreased in cholangiocarcinoma patient samples compared to the adjacent normal bile duct samples. …”
  16. 1336

    Image_4_miR-144-5p and miR-451a Inhibit the Growth of Cholangiocarcinoma Cells Through Decreasing the Expression of ST8SIA4.tif by Wan Fu (3681799)

    Published 2021
    “…This study aimed to investigate the action mechanism of miR-144-5p and miR-451a in cholangiocarcinoma. We found that miR-144-5p and miR-451a were significantly decreased in cholangiocarcinoma patient samples compared to the adjacent normal bile duct samples. …”
  17. 1337

    Image_3_miR-144-5p and miR-451a Inhibit the Growth of Cholangiocarcinoma Cells Through Decreasing the Expression of ST8SIA4.tif by Wan Fu (3681799)

    Published 2021
    “…This study aimed to investigate the action mechanism of miR-144-5p and miR-451a in cholangiocarcinoma. We found that miR-144-5p and miR-451a were significantly decreased in cholangiocarcinoma patient samples compared to the adjacent normal bile duct samples. …”
  18. 1338
  19. 1339

    Decreased Ly6G<sup>+</sup> neutrophils in the presence of PLD inhibitors using IF microscopy of lung sections. by Karen M. Henkels (3350273)

    Published 2016
    “…(<b>A,A’,E</b>) Tissues from non-xenographed controls; (<b>B,B’,F</b>) from Xenotransplanted controls with Alzet pumps delivering vehicle; (<b>C,C’,G</b>) Xenotransplanted with Alzet pumps delivering vehicle FIPI or (<b>D,D’,H</b>) VU0155072-2. …”
  20. 1340